Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Haemonetics Corp
(NY:
HAE
)
95.73
+0.93 (+0.98%)
Official Closing Price
Updated: 4:10 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Haemonetics Corp
< Previous
1
2
3
4
Next >
Cutera Stock Earns Relative Strength Rating Upgrade
October 03, 2022
On Monday, medical aesthetic Cutera stock had its Relative Strength (RS) Rating upgraded to 90 from 80 a day earlier.
Via
Investor's Business Daily
Important Biotech Catalysts For September 12, 2022 - End Of The Day Summary
September 12, 2022
Via
Benzinga
Watch for Continued Gains in Shares of Haemonetics Corporation (HAE)
September 12, 2022
Via
Investor Brand Network
Stock Market Rally Rises On Inflation Data; Nvidia, Micron, Tesla, Disney In Focus: Weekly Review
August 12, 2022
The major indexes continued to advance, despite some key warnings.
Via
Investor's Business Daily
Where Haemonetics Stands With Analysts
August 11, 2022
Within the last quarter, Haemonetics (NYSE:HAE) has observed the following analyst ratings:
Via
Benzinga
Haemonetics: Q1 Earnings Insights
August 10, 2022
Haemonetics (NYSE:HAE) reported its Q1 earnings results on Wednesday, August 10, 2022 at 06:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Haemonetics Stock Near Buy Zone With EPS Due
July 27, 2022
With its next earnings report scheduled for around Aug. 10, Haemonetics stock is trading about 10% shy of a 75.44 buy point.
Via
Investor's Business Daily
Haemonetics Surges Closer To A Breakout After Squashing Quarterly Estimates, Raising Guidance
August 10, 2022
The blood and plasma supplies provider also raised its sales guidance for the fiscal year.
Via
Investor's Business Daily
InMode Stock Scores Relative Strength Rating Upgrade; Hits Key Threshold
August 09, 2022
On Tuesday, InMode stock got a positive adjustment to its Relative Strength (RS) Rating, to 86 from 72 a day earlier.
Via
Investor's Business Daily
ShockWave Medical Stock Scores Rising Price Performance With Jump To 92 RS Rating
July 11, 2022
ShockWave Medical stock saw a welcome improvement to its Relative Strength (RS) Rating on Monday, with an increase from 81 to 92.
Via
Investor's Business Daily
Raymond James Thinks Haemonetics Growth Is 'Underappreciated'
July 01, 2022
Via
Benzinga
Morgan Stanley Maintains Equal-Weight Rating for Haemonetics: Here's What You Need To Know
July 01, 2022
Morgan Stanley has decided to maintain its Equal-Weight rating of Haemonetics (NYSE:HAE) and raise its price target from $60.00 to $70.00. Shares of Haemonetics are trading up 1.46% over the last 24...
Via
Benzinga
4 Analysts Have This to Say About Haemonetics
July 01, 2022
Over the past 3 months, 4 analysts have published their opinion on Haemonetics (NYSE:HAE) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
Haemonetics: Q4 Earnings Insights
May 10, 2022
Haemonetics (NYSE:HAE) reported its Q4 earnings results on Tuesday, May 10, 2022 at 06:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Analyst Ratings For Haemonetics
February 09, 2022
Analysts have provided the following ratings for Haemonetics (NYSE:HAE) within the last quarter:
Via
Benzinga
Why Haemonetics Shares Are Trading Higher Today?
February 08, 2022
Haemonetics Corporation (NYSE: HAE) posted
Via
Benzinga
Needham Sees Reasonable Forecasts For Haemonetics, With Some Tailwinds
June 15, 2022
Haemonetics Corporation's (NYSE: HAE) analyst day later this month may include an update on its businesses, new products, margin outlook, and financial targets for FY24-FY26.
Via
Benzinga
ShockWave Medical Stock Shows Rising Price Performance With Jump To 91 RS Rating
June 13, 2022
On Monday, ShockWave Medical stock received an upgrade to its Relative Strength (RS) Rating, from 86 to 91.
Via
Investor's Business Daily
77 Stocks Moving In Tuesday's Mid-Day Session
May 10, 2022
Gainers
Via
Benzinga
Recap: Haemonetics Q3 Earnings
February 08, 2022
Haemonetics (NYSE:HAE) reported its Q3 earnings results on Tuesday, February 8, 2022 at 06:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
103 Biggest Movers From Yesterday
May 11, 2022
Gainers
Via
Benzinga
The Week Ahead In Biotech (May 8-14): Bausch Health Headlines Smid-Cap Earnings, Veru's Pre-EUA Meeting, Conference Presentations And More
May 09, 2022
Biotech stocks declined yet again in the week ending May 6, dragged lower by macroeconomic concerns following the Federal Reserve's 50-basis-point rate hike. The iShares Biotechnology ETF (NASDAQ:...
Via
Benzinga
10 Biggest Price Target Changes For Wednesday
February 09, 2022
Cowen & Co. cut the price target on Chipotle Mexican Grill, Inc. (NYSE: CMG) from $2,250 to $1,950. Chipotle shares rose 6.1% to $1,549.97 in pre-market trading.
Via
Benzinga
Mid-Afternoon Market Update: Nasdaq Surges 100 Points; Graham Shares Plunge
February 08, 2022
US stocks extended gains later in the session, with the Nasdaq index surging 100 points on Tuesday.
Via
Benzinga
51 Biggest Movers From Yesterday
February 09, 2022
Also check out this: Apple And 3 Other Stocks Sold By Insiders Losers SelectQuote, Inc. (NYSE: SLQT) shares tumbled 47.3% to close at $3.44 on Tuesday after the company...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 08, 2022
Gainers BioCardia (NASDAQ:BCDA) stock inc...
Via
Benzinga
Mid-Day Market Update: Pfizer Sales Miss Expectations; Teradata Shares Spike Higher
February 08, 2022
US stocks remained mostly higher on Tuesday, while the S&P 500 traded lower by 0.1%.
Via
Benzinga
35 Stocks Moving In Tuesday's Mid-Day Session
February 08, 2022
Gainers Society Pass Incorporated (NASDAQ: SOPA) gained 63.4% to $3.45 after dropping 16% on Monday. American Rebel Holdings, Inc. (NASDAQ: AREB) climbed 56.1% to $3.45 following...
Via
Benzinga
The Daily Biotech Pulse: Pfizer, Amgen Shares Slip On Earnings, Editas Terminates Chief Medical Officer, Biogen Licenses Preclinical Rheumatoid Arthritis Biosimilar
February 08, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Earnings Scheduled For February 8, 2022
February 08, 2022
Companies Reporting Before The Bell • Pfizer (NYSE:PFE) is likely to report quarterly earnings at $0.87 per share on revenue of $24.20 billion.
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.